[go: up one dir, main page]

EA200200750A1 - Новое терапевтическое применение еноксапарина - Google Patents

Новое терапевтическое применение еноксапарина

Info

Publication number
EA200200750A1
EA200200750A1 EA200200750A EA200200750A EA200200750A1 EA 200200750 A1 EA200200750 A1 EA 200200750A1 EA 200200750 A EA200200750 A EA 200200750A EA 200200750 A EA200200750 A EA 200200750A EA 200200750 A1 EA200200750 A1 EA 200200750A1
Authority
EA
Eurasian Patent Office
Prior art keywords
enoxaparin
new therapeutic
therapeutic application
published
treatment
Prior art date
Application number
EA200200750A
Other languages
English (en)
Other versions
EA006035B1 (ru
Inventor
Вероник Мари
Жан-Мари Штуцманн
Андре Юзан
Флоранс Валь
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200200750A1 publication Critical patent/EA200200750A1/ru
Publication of EA006035B1 publication Critical patent/EA006035B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению еноксапарина для лечения ишемии мозга.Отчет о международном поиске был опубликован 2002.04.04.
EA200200750A 2000-01-06 2001-01-03 Новое терапевтическое применение еноксапарина EA006035B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (fr) 2000-01-06 2000-01-06 Nouvelle application therapeutique de l'enoxaparine
PCT/FR2001/000014 WO2001049298A2 (fr) 2000-01-06 2001-01-03 Nouvelle application therapeutique de l"enoxaparine

Publications (2)

Publication Number Publication Date
EA200200750A1 true EA200200750A1 (ru) 2003-02-27
EA006035B1 EA006035B1 (ru) 2005-08-25

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200750A EA006035B1 (ru) 2000-01-06 2001-01-03 Новое терапевтическое применение еноксапарина

Country Status (30)

Country Link
EP (1) EP1248638B1 (ru)
JP (1) JP2003519185A (ru)
KR (1) KR20020069240A (ru)
CN (1) CN1400905A (ru)
AR (1) AR026804A1 (ru)
AT (1) ATE344671T1 (ru)
AU (1) AU784656B2 (ru)
BR (1) BR0107442A (ru)
CA (1) CA2396178A1 (ru)
CZ (1) CZ20022303A3 (ru)
DE (1) DE60124373T2 (ru)
DK (1) DK1248638T3 (ru)
EA (1) EA006035B1 (ru)
EE (1) EE200200374A (ru)
ES (1) ES2275648T3 (ru)
FR (1) FR2803522B1 (ru)
HK (1) HK1052649A1 (ru)
HR (1) HRP20020573A2 (ru)
HU (1) HUP0204040A3 (ru)
IL (1) IL150477A0 (ru)
MX (1) MXPA02006672A (ru)
NO (1) NO20023243D0 (ru)
NZ (1) NZ520283A (ru)
PL (1) PL357192A1 (ru)
PT (1) PT1248638E (ru)
SK (1) SK9612002A3 (ru)
UA (1) UA75587C2 (ru)
WO (1) WO2001049298A2 (ru)
YU (1) YU51802A (ru)
ZA (1) ZA200205415B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231358C2 (ru) * 2002-06-11 2004-06-27 Научно-исследовательский институт кардиологии Томского научного центра СО РАМН Способ лечения острого коронарного синдрома без подъема сегмента st
AR063530A1 (es) * 2006-10-30 2009-01-28 Aventis Pharma Sa Procedimiento de utilizacion de enoxaparina sodica para la preparacion de un medicamento
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Also Published As

Publication number Publication date
PL357192A1 (en) 2004-07-26
EP1248638A2 (fr) 2002-10-16
EE200200374A (et) 2003-12-15
FR2803522B1 (fr) 2004-01-02
MXPA02006672A (es) 2002-09-30
EP1248638B1 (fr) 2006-11-08
CZ20022303A3 (cs) 2002-11-13
EA006035B1 (ru) 2005-08-25
HUP0204040A2 (hu) 2003-04-28
WO2001049298A2 (fr) 2001-07-12
DE60124373D1 (de) 2006-12-21
ATE344671T1 (de) 2006-11-15
IL150477A0 (en) 2002-12-01
AU3183001A (en) 2001-07-16
PT1248638E (pt) 2007-02-28
HRP20020573A2 (en) 2003-10-31
AR026804A1 (es) 2003-02-26
CA2396178A1 (fr) 2001-07-12
SK9612002A3 (en) 2002-12-03
YU51802A (sh) 2005-06-10
ZA200205415B (en) 2003-10-13
ES2275648T3 (es) 2007-06-16
DK1248638T3 (da) 2007-03-19
BR0107442A (pt) 2002-10-08
HK1052649A1 (zh) 2003-09-26
UA75587C2 (en) 2006-05-15
NO20023243L (no) 2002-07-04
WO2001049298A3 (fr) 2002-04-04
DE60124373T2 (de) 2007-08-30
AU784656B2 (en) 2006-05-18
JP2003519185A (ja) 2003-06-17
NO20023243D0 (no) 2002-07-04
HUP0204040A3 (en) 2003-05-28
CN1400905A (zh) 2003-03-05
NZ520283A (en) 2004-09-24
KR20020069240A (ko) 2002-08-29
FR2803522A1 (fr) 2001-07-13

Similar Documents

Publication Publication Date Title
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
EA200200306A1 (ru) Трициклические ингибиторы поли(адф-рибозо)полимераз
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
EA200500169A1 (ru) Замещенные производные 1,3-дифенилпроп-2-ен-1-она, получение и применение
BG66084B1 (bg) Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
EE200200461A (et) Pteridiiniühendid psoriaasi raviks
EE200100485A (et) Uudsed ühendid ja kompositsioonid proteaasi inhibiitoritena
BG66085B1 (bg) Фенилаланинови производни
EE200200172A (et) Ühendid isheemia ravimiseks
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
DE60121461D1 (de) Kondensierte pyridoindolderivate
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
SE9901077D0 (sv) Novel use
PT1321135E (pt) Composicao para o tigimento de oxidacao das fibras ceratinicas
HN2002000110A (es) Uso de (z) - 2 - ciano - 3 - hidroxi - butil - 2 - acido enoico (4' - trifluorometil fenilo) - amida para el tratamiento de la esclerosis multiple.
DK1463735T3 (da) Imidazo-2,1-B -1,3,4-thiadiazol-sulfonamider
SE9801494D0 (sv) Novel use
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
DE60112960D1 (de) Kondensierte pyridoindolderivate
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
YU60101A (sh) Derivati rezorcinola
EA200200948A1 (ru) Лечение псориаза

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU